scispace - formally typeset
H

Hossein Baharvand

Researcher at University of Science and Culture

Publications -  487
Citations -  20462

Hossein Baharvand is an academic researcher from University of Science and Culture. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 56, co-authored 454 publications receiving 15081 citations. Previous affiliations of Hossein Baharvand include Avicenna Research Institute & Royan Institute.

Papers
More filters
Journal ArticleDOI

In vivo conversion of astrocytes to myelinating cells by miR-302/367 and valproate to enhance myelin repair.

TL;DR: It is suggested that in vivo specific targeting of astrocytes for forced expression of the miR‐302/367 cluster and VPA administration may increase the brain's potential for repairing myelin insults by the generation of oligodendroglia from astroCytes.
Journal ArticleDOI

Treatment of Human Embryonic Stem Cells with Different Combinations of Priming and Inducing Factors Toward Definitive Endoderm

TL;DR: Data have indicated that hESCs primed with Rapa, and induced by a lower concentration of activin A, could lead to DE that had the capability to further differentiate into HLCs and PP cells, but not PE cells.
Journal ArticleDOI

Delay in apoptosome formation attenuates apoptosis in mouse embryonic stem cell differentiation.

TL;DR: Investigating the role of the mitochondrial apoptotic pathway and cell energy level during differentiation of mESCs into the cardiomyocytes and their apoptosis suggests that a delay in the release of cytochrome c or delay in ATP increase attenuate apoptosome formation, and caspase activation thereby discriminates apoptosis from differentiation in mEScs.
Journal ArticleDOI

Ultrastructural comparison of developing mouse embryonic stem cell- and in vivo-derived cardiomyocytes.

TL;DR: The data suggest that ESCs can differentiate into functional mature CMs in vitro and may provide an ideal model for the study of cardiomyocytic development and may be useful for cell therapy of various cardiac diseases.